Overview
Ann Beasley is a Managing Director in the Life Sciences and Healthcare Consulting Group at Paul Hastings and is based in the firm’s Boston office. Ann is an adept bio-pharmaceutical executive with over 25 years of experience across a range of life sciences companies and therapy areas. She has worked at start-ups and multinationals, and both public and privately held companies in the pharmaceutical, biotech, and medical device spaces.
Ann has held leadership roles at diagnostic, genetic testing/laboratory, and generics companies; she has built and overseen complex single country compliance programs as well as global compliance programs across multiple jurisdictions with upwards of 80 functional reports. Her specialties include building Ethics and Compliance programs, designing comprehensive risk management organizations scaled to company size/complexity, and working directly with executive management and Boards of Directors to help ensure that the company manages risk as appropriate to the activities the company conducts, the jurisdictions in which it operates, and the sectors and market environment in which it competes.
Education
- INSEAD: Healthcare Compliance Implementation Leadership Program
- Northeastern University School of Law: Juris Doctorate; admitted to the Massachusetts Bar
- University of Tulsa: Bachelor’s Degree in Communications
Representations
- Having spent the majority of her career working in house, Ann has wide-ranging experience across core Legal and Ethics & Compliance program attributes through her experience working at Genzyme, Boehringer Ingelheim Pharmaceuticals, Sepracor, Novartis Vaccines & Diagnostics, Novartis Pharma AG, Biogen, and Zai Lab.
- Ann’s core skills include risk assessment (Enterprise-wide and Healthcare Compliance); program assessments (PhRMA, EFPIA, IFPMA, ABAC); global policies and procedures; global training programs; global monitoring programs; implementation and management of hot/helpline reporting systems; developing and overseeing investigations protocols and resolution processes; developing governance committees (Global & Local Compliance; Risk Management; Grants; Donations; etc.); and Board/Audit Committee reporting.
- Regularly called upon to contribute insights to deal committees – both on the in-licensing side as well as part of M&A activity. For example, she participated as a key member in the evaluation of a multinational company’s purchase of a China-based vaccine manufacturer – during which she collaborated with company Legal and Compliance personnel to develop a compliance and legal operational checklist for use in deal evaluations.
- Has shared her in-house experience with her clients during several years of consulting in the Governance, Risk, and Compliance (GRC) space within the life sciences industry. Ann has performed numerous risk assessments; advised Boards of Directors on client activities and Board compliance obligations; and led Independent Review Organization (“IRO”) engagements for companies operating under Corporate Integrity Agreements (“CIAs”).
Engagement & Publications
- Regular speaker at multiple global Compliance forums such as PCF (Pharmaceutical Compliance Forum); PCC (Pharmaceutical Compliance Congress), the Compliance Congress for Specialty Products; and various ACI (American Conference Institute) conferences. She is a founding member and a former Strategic Committee member of ETHICS, a professional society for Compliance Officers in the life sciences industry. Ann is also a regular instructor at INSEAD’s Healthcare Compliance Implementation Leadership Program (“HCLIP”)
Involvement
- Ann is co-founder and President of Next Generation Investment, Inc. (NGI) - a non-profit organization that focuses on improving teachers’ in-classroom skills in economically disadvantaged areas around the globe. NGI is currently focused on the Monduli district in Arusha, Tanzania, where the rural schools are predominantly Maasai and teachers often must lead classrooms with over 50 students across multiple grade levels. NGI provides in-person workshops and conducts site visits to support these educators in optimizing their limited resources.